With a combined 150 years of PET experience, ABT’s team has a long history in PET imaging. ABT’s team, founded by Dr. Ronald Nutt who commercialized PET imaging while at CTI Molecular Imaging, Inc., includes individuals from the PET biomarker distribution, PET imaging and radiochemistry industries. The team is anchored around our many talented accelerator scientists and technicians, as well as veterans of medical device manufacturing outside of PET. Partners, brokers, distributors and other global stakeholders work with ABT to expand the utility and presence of the Biomarker Generator.
Rick Rippin joined ABT as Sales Director in late 2009 to establish a worldwide sales infrastructure for the “Dose on Demand” Biomarker Generator. Mr. Rippin has over 20 years of experience in sales and marketing in the diagnostic imaging industry. Prior to his role at ABT, he managed Molecular Imaging Sales with Siemens Medical Solutions, Toshiba America Medical Systems, and Naviscan. Mr. Rippin received his BS Degree from Towson University, and Nuclear Medicine Degree from Johns Hopkins University.
Rudi Verbruggen joined ABT as the Managing Director in Europe, the Middle East and Africa in July 2013. Prior to joining ABT, Mr. Verbruggen served as the Managing Director for PETNET biomarkers and cyclotrons in Europe, the Middle East and Africa as well as the Managing Director for CTI in Europe and the Middle East. With over 20 years experience in PET, Mr. Verbruggen brings extensive knowledge and technical skills to the ABT team. Mr. Verbruggen has studied both engineering and business and holds a Ph. D. from the University of Pretoria.